Relay Therapeutics Inc. to Participate in Investor Conferences in June

Relay Therapeutics, Inc., a biotechnology company based in Cambridge, United States, has announced its participation in two investor conferences scheduled for June. The company, which operates in the health care sector, specializes in developing drugs for the treatment of cancer and serves its customers exclusively within the United States. Relay Therapeutics is listed on the Nasdaq stock exchange.

Over the past year, the company’s stock price has experienced significant fluctuations. The 52-week high was recorded at $10.72 on September 8, 2024, while the 52-week low was $1.775 on April 6, 2025. As of the last close on May 29, 2025, the stock price stood at $3.

The company’s financial metrics present a complex valuation picture. The price-to-earnings ratio is currently -1.27, and the price-to-book ratio is 0.67264. Relay Therapeutics has a market capitalization of $487,760,000 USD.

Relay Therapeutics’ participation in the upcoming investor conferences is expected to provide an opportunity for the company to engage with investors and discuss its strategic direction and developments in its drug development pipeline. For more information, stakeholders can visit the company’s website at www.relaytx.com .